Stem Cells and Disease Modeling
Human pluripotent stem cells (hPSCs) offer a useful model system for understanding the genetic basis of human cardiovascular diseases. Unlike nonhuman animal models, hPSCs are often tightly genetically matched to patients with disease. Previously, only in unusual circumstances was it feasible to review primary tissues like heart muscle and blood vessels obtained directly from living patients, and even in such circumstances, the quantity of tissue was limited. hPSCs represent a replacement approach that gives an unprecedented opportunity to review human cells that are matched to the patients of interest. Because they will be expanded into very large numbers and differentiated into a spread of cell types that are relevant to cardiovascular diseases—including cardiomyocytes, vascular endothelial and smooth muscle cells, and hepatocytes—hPSCs can in theory provide a limitless source of fabric with which to dissect the molecular underpinnings of the patient’s disease process within and beyond the circulatory system.
Related Conference of Stem Cells and Disease Modeling
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cells and Disease Modeling Conference Speakers
Recommended Sessions
- 3D Bio-Printing and Organ Printing
- Advances in Stem Cells and their Niches
- Biobanking
- Biomaterials and Biomedical Applications
- Bone Marrow Transplantation
- Cancer Stem Cell and Oncology
- Cell and Gene Therapy
- Cell Biology
- Cell Therapy for Cardiovascular and Neurological Disorders
- COVID-19 and Convalescent Plasma
- Novel Stem Cell Techniques
- Stem Cell & Regenerative Medicine research and development
- Stem Cell in Drug Discovery
- Stem Cells
- Stem Cells and Disease Modeling
- Stem Cells and Veterinary Applications
- Tissue Engineering
- Translational Research in Stem Cell Assessments
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
